Abstract
B-cell receptor (BCR) signaling is essential for the development of B cells and has a critical role in B-cell neoplasia. Increasing evidence indicates an association between chronic hepatitis C virus (HCV) infection and B-cell lymphoma, however, the mechanisms by which HCV causes B-cell lymphoproliferative disorder are still unclear. Herein, we demonstrate the expression of HCV viral proteins in B cells of HCV-infected patients and show that HCV upregulates BCR signaling in human primary B cells. HCV nonstructural protein NS3/4A interacts with CHK2 and downregulates its activity, modulating HuR posttranscriptional regulation of a network of target mRNAs associated with B-cell lymphoproliferative disorders. Interestingly, the BCR signaling pathway was found to have the largest number of transcripts with increased association with HuR and was upregulated by NS3/4A. Our study reveals a previously unidentified role of NS3/4A in regulation of host BCR signaling during HCV infection, contributing to a better understanding of the molecular mechanisms underlying HCV-associated B-cell lymphoproliferative disorders.
Original language | English (US) |
---|---|
Pages (from-to) | 2979-2990 |
Number of pages | 12 |
Journal | Oncogene |
Volume | 35 |
Issue number | 23 |
DOIs | |
State | Published - Jun 9 2016 |
Funding
This work was supported in part by a Merit Review Award from the Department of Veterans Affairs (RBG), R01AA017972 (RBG) and R01CA164311 (RBG) from the National Institutes of Health, as well as MOP-126056 (TIM) from the Canadian Institutes of Health Research and the Canada Research Chair Program in Viral Hepatitis/Immunology (TIM). This research was also supported in part by the Intramural Research Program of the NIH, National Institute on Aging (YZ, EL and KGB).
ASJC Scopus subject areas
- Molecular Biology
- Genetics
- Cancer Research